合作机会:在儿科中抗菌和诊断管理之间的协同作用
Brandy M Hoyt1, Kevin Messacar1,2, Anna C Sick-Samuels3,4
1Department of Pediatrics, Section of Hospital Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Antimicrobial stewardship & healthcare epidemiology : ASHE
|February 14, 2025
概括
儿科的抗微生物管理 (AS) 和诊断管理 (DS) 计划需要合作. 本综述概述了五个关键的合作时刻,以改善患者护理和减少浪费.
科学领域:
- 提高儿科医疗保健质量 提高儿科医疗保健质量
- 传染病管理 传染病管理
- 临床实验室科学 临床实验室科学
背景情况:
- 抗生素管理 (AS) 计划对于优化抗生素使用和打击耐药性至关重要.
- 在AS项目中,通过连接临床和实验室的利益相关者,本质上涉及诊断管理 (DS).
- 有效的合作对于在儿科环境中推进高价值护理至关重要.
研究的目的:
- 为了说明AS和DS在儿科中的协同作用.
- 识别和描述AS和DS利益相关者之间合作的五个关键时刻.
- 提供AS-DS协作在儿科诊断中的实例.
主要方法:
- 本综述综合了有关AS和DS在儿科护理中的当前文献.
- 它通过五个不同的时刻来概念化协作:观察,反思,探索,实施和评估.
- 来自常见的儿科诊断场景的案例例子被用来说明这些时刻.
主要成果:
- 确定并详细介绍了AS和DS利益相关者之间合作的五个关键时刻.
- 这些例子展示了这些合作如何影响儿科样本的诊断使用 (例如,内胃吸血剂,血液培养,胃肠道样本,尿液).
- 集成AS和DS可以减少财务和环境浪费.
结论:
- 儿童抗菌药物管理的成功发展需要综合诊断管理.
- 这五个确定的时刻为加强AS和DS团队之间的合作提供了一个框架.
- 通过管理来优化诊断过程可以改善患者的治疗结果和资源利用.
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:28Pulmonary Tuberculosis V
168
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
168
01:22Healthcare Associated Infections II: Preventive Measures
2.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.4K
01:31Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
00:57Antibiotic Selection
52.2K
Overview
52.2K
01:28Pneumonia IV: Management
287
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
287